Merck Keytruda gets full USFDA approval for advanced MSI-H or dMMR solid tumors Ruchika Sharma1 April 2023 6:45 AM GMTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Import duty exempted on all drugs, food for special medical purposes for personal use to treat rare diseases Ruchika Sharma31 March 2023 7:33 AM GMTNew Delhi: The government has exempted basic customs duty on all drugs and food for special medical purposes imported for personal use for treatment...
KEYTRUDA plus chemotherapy improves overall survival versus chemotherapy alone to treat advanced malignant pleural mesothelioma: Merck Ruchika Sharma13 March 2023 8:57 AM GMTMalignant mesothelioma is a type of cancer that starts in the linings of certain parts of the body, including the chest, abdomen, heart and
Merck scraps another prostate cancer study as Keytruda therapy disappoints Ruchika Sharma1 March 2023 8:45 AM GMTNew Delhi: Merck & Co said on Tuesday it will stop a late-stage trial evaluating a combination therapy with its cancer drug Keytruda after interim...
Moderna-Merck gets USFDA Breakthrough Therapy Designation for personalized mRNA cancer vaccine in combination with KEYTRUDA to treat high risk melanoma Ruchika Sharma23 Feb 2023 9:15 AM GMTCambridge: Moderna, Inc. and Merck have announced that mRNA-4157/V940, an investigational personalized mRNA cancer vaccine, in combination with...
Merck announces positive results from phase 3 KEYNOTE-859 trial of Keytruda plus chemotherapy to treat patients with HER2-negative gastric or GEJ adenocarcinoma Ruchika Sharma20 Feb 2023 9:00 AM GMTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
Wellmarker Bio enters clinical trial collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA Ruchika Sharma9 Feb 2023 8:45 AM GMTWM-A1-3389 is a novel therapeutic antibody targeting a new immune checkpoint protein discovered by Wellmarker Bio and has demonstrated efficacy across...
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer Ruchika Sharma30 Jan 2023 9:15 AM GMTKEYTRUDA is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body's immune system to help detect and...
MSD bags DCGI nod for Keytruda to treat cervical cancer Ruchika Sharma25 Jan 2023 7:00 AM GMTMumbai: Drugs Controller General of India (DCGI) has approved Keytruda (pembrolizumab), MSD’s anti-PD-1 therapy, for the treatment of persistent,...
Merck, Antengene collaborate to test Keytruda, ATG-037 combo for solid tumors in phase 1 trial Ruchika Sharma31 Dec 2022 6:00 AM GMTATG-037 is an orally available, small molecule CD73 inhibitor.
Merck secures USFDA priority review for PADCEV with KEYTRUDA for treatment of Urothelial Cancer Ruchika Sharma22 Dec 2022 9:51 AM GMTPADCEV (enfortumab vedotin-ejfv) is a first-in-class antibody-drug conjugate (ADC) that is directed against Nectin-4, a protein located on the surface...
Merck hopes to patent subcutaneous version of blockbuster cancer drug Keytruda Ruchika Sharma3 Dec 2022 9:01 AM GMTMerck's patents on the subcutaneous version of Keytruda could protect that formulation until at least 2040, according to Tahir Amin, co-founder of...
